Streetbeat News

Stock Prices

UXIN

Uxin shares rose following the announcement of a year-over-year increase in Q1 sales results.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:14 pm

NVO

Novo Nordisk's CEO, Lars Fruergaard Jørgensen, will face the U.S. Senate Committee on Health, Education, Labor, and Pensions regarding the high prices of Ozempic and Wegovy. The hearing, led by Senator Bernie Sanders, will scrutinize the company's pricing strategy, which is significantly higher in the U.S. compared to other countries. Novo Nordisk is expected to defend its pricing by citing insurance coverage and development costs, despite criticism and potential inclusion in Medicare's negotiated drug prices.

Portfolio Pulse from Vandana Singh

September 23, 2024 | 5:11 pm

TGL

Treasure Global's stock price increased following the announcement of a partnership with Credilab.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:10 pm

AMZN

GOOGL

MSFT

NVDA

DA Davidson analyst Gil Luria downgraded Microsoft to Neutral, citing increased competition from Amazon and Google in AI and cloud services. Microsoft's lead in AI has diminished, impacting its premium valuation. The company faces challenges in maintaining its growth and margins.

Portfolio Pulse from Anusuya Lahiri

September 23, 2024 | 5:10 pm

VNCE

Vince Holding Corp has filed with the SEC for a stock shelf offering of up to $10 million. This move allows the company to issue new shares to raise capital, which could be used for various corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:07 pm

RSLS

ReShape Lifesciences shares were halted due to a circuit breaker as the stock surged by 47.8%.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:06 pm

RSLS

ReShape Lifesciences shares have resumed trading, which could indicate a resolution of previous issues that halted trading.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:05 pm

RSLS

ReShape Lifesciences shares were halted due to a circuit breaker as the stock surged by 34.2%.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:03 pm

NVST

Envista Holdings (NYSE:NVST) has received mixed analyst ratings over the past three months, with a recent downward trend in price targets. The company's financial metrics, such as revenue growth and net margin, are below industry averages, indicating potential challenges. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 5:01 pm

REGN

Financial giants are making bearish moves on Regeneron Pharmaceuticals (NASDAQ:REGN) through options trading. Analysis shows 50% bearish sentiment with significant trades in puts and calls. The stock is currently down 3.02% at $1110.5, with analysts providing mixed ratings and price targets.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 5:01 pm